We are live on ! Find out more
GYRE icon

Gyre Therapeutics
GYRE

71 hedge funds and large institutions have $114M invested in Gyre Therapeutics in 2013 Q2 according to their latest regulatory filings, with 71 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

81% less call options, than puts

Call options by funds: $1.26M | Put options by funds: $6.73M

Holders
71
Holders Change
+71
Holders Change %
–
% of All Funds
2.32%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
71
Increased
–
Reduced
–
Closed
–
Calls
$1.26M
Puts
$6.73M
Net Calls
-$5.47M
Net Calls Change
-$5.47M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
51
Panagora Asset Management
Massachusetts
$129K +$145K +38 New
ProShare Advisors
52
ProShare Advisors
Maryland
$102K +$114K +30 New
Prudential Financial
53
Prudential Financial
New Jersey
$99K +$114K +30 New
JP Morgan Chase
54
JP Morgan Chase
New York
$92K +$103K +27 New
HCM
55
Highbridge Capital Management
New York
$89K +$103K +27 New
AIG
56
American International Group
New York
$82.2K +$91.3K +24 New
BA
57
BlackRock Advisors
Delaware
$73K +$83.7K +22 New
SIM
58
Spark Investment Management
New York
$70K +$79.9K +21 New
FSA
59
Franklin Street Advisors
North Carolina
$64K +$72.3K +19 New
Principal Financial Group
60
Principal Financial Group
Iowa
$55K +$60.9K +16 New
Bank of America
61
Bank of America
North Carolina
$53K +$60.9K +16 New
Citigroup
62
Citigroup
New York
$53K +$60.9K +16 New
Jane Street
63
Jane Street
New York
$53K +$60.9K +16 New
BNP Paribas Financial Markets
64
BNP Paribas Financial Markets
France
$49.4K +$57.1K +15 New
Citadel Advisors
65
Citadel Advisors
Florida
$35K +$38K +10 New
Manulife (Manufacturers Life Insurance)
66
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$29K +$34.2K +9 New
TRCT
67
Tower Research Capital (TRC)
New York
$19K +$22.8K +6 New
Ameriprise
68
Ameriprise
Minnesota
$7K +$7.61K +2 New
FA
69
Financial Advantage
Maryland
$6K +$7.61K +2 New
GT
70
Glenmede Trust
Pennsylvania
$5K +$7.61K +2 New
JAM
71
Jolley Asset Management
North Carolina
$2K +$3.81K +1 New
PFG
72
Piershale Financial Group
Illinois
$1K – – –
1 2
3

GYRE Hedge Fund Activity: Q2 2013 in Review

71 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Gyre Therapeutics (GYRE) for Q2 2013, worth a combined $114M.

Buyers outnumbered sellers: 71 funds opened new GYRE positions and 0 closed out — a net gain of 71 holders — while 0 added to existing stakes and 0 trimmed.

  • 71 institutional investors held Gyre Therapeutics (GYRE) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $114M of Gyre Therapeutics stock for Q2 2013.
  • 71 funds opened new Gyre Therapeutics positions in Q2 2013 and 0 closed out, a net change of +71 holders.

Based on aggregated 13F filings for Q2 2013.